Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
- Guggenheim 3rd Annual
Neuro/Immunology Conferenceon Monday, November 15, 2021(one-on-one meetings only)
- Stifel 2021
Virtual Healthcare Conferenceon Wednesday, November 17, 2021, with fireside chat presentation at 1:20 pm ET Jefferies London Healthcare Conferenceon Thursday, November 18, 2021, with on-demand streaming of fireside chat presentation beginning at 8:00 am GMT/ 3:00 am ET
The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event.
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of
Source: Xenon Pharmaceuticals Inc.